Glatstein E
Cancer. 1977 Feb;39(2 Suppl):837-42. doi: 10.1002/1097-0142(197702)39:2+<837::aid-cncr2820390719>3.0.co;2-f.
Improvements in results of treatment for Hodgkin's disease have been dramatic in the last 20 years. The results of high dose radiation therapy are reviewed in terms of the importance of the extent of the field of irradiation. The importance of adjuvant chemotherapy is also discussed. Problem areas both in staging and in general management of patients with Hodgkin's disease are emphasized. Long-term complications of treatment, both radiotherapeutic and chemotherapeutic are stressed. The excellent results of management for stage I, II (A and B), and IIIA Hodgkin's disease have reached a level at which future studies must aim at reducing the morbidity of treatment.
在过去20年里，霍奇金淋巴瘤的治疗效果有了显著改善。本文根据照射野范围的重要性，对高剂量放射治疗的结果进行了综述。同时也讨论了辅助化疗的重要性。强调了霍奇金淋巴瘤患者分期及总体管理中的问题领域。着重指出了放射治疗和化学治疗的长期并发症。I期、II期（A和B）及IIIA期霍奇金淋巴瘤的良好治疗效果已达到一定水平，未来研究必须致力于降低治疗的发病率。
